BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2618701)

  • 21. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
    Denney RM; Fritz RR; Patel NT; Widen SG; Abell CW
    Mol Pharmacol; 1983 Jul; 24(1):60-8. PubMed ID: 6191193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of some anxiogenic agents on rat brain monoamine oxidase (MAO) A and B inhibitory (tribulin) activity.
    Bhattacharya SK; Chakrabarti A; Sandler M; Glover V
    Indian J Exp Biol; 1996 Dec; 34(12):1190-3. PubMed ID: 9246908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
    Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent.
    Yu PH
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):163-71. PubMed ID: 3961266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental aspects of the monoamine-degrading enzyme monoamine oxidase.
    Strolin Benedetti M; Dostert P; Tipton KF
    Dev Pharmacol Ther; 1992; 18(3-4):191-200. PubMed ID: 1306808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Age changes in brain monoamine oxidase in mice from four lines].
    Voĭtenko NN
    Vopr Med Khim; 1992; 38(3):32-5. PubMed ID: 1413646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of styrene on monoamine oxidase B activity in rat brain.
    Coccini T; Randine G; Li B; Manzo L; Costa LG
    J Toxicol Environ Health A; 1999 Jan; 56(1):59-68. PubMed ID: 9923754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of acetylcholine on monoamine oxidase A and B activity in different parts of rat brain.
    Osman MY; Osman HM
    Arzneimittelforschung; 2008; 58(10):493-6. PubMed ID: 19025057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of D,L-malic acid dibenzylhydrazide on changes in the antioxidizing activity of lipids and monoamine oxidase activity in mouse organs].
    Kairane ChB; Baumanis EA; Burlakova EB; Gorkin VZ; Kalninia IE
    Vopr Med Khim; 1979; 25(6):776-81. PubMed ID: 516540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monamine oxidase activity of the brain and liver mitochondria under the action of high-pressure oxygen on animals].
    Bronovitskaia ZG; Goroshinskaia IA
    Ukr Biokhim Zh; 1976; 48(3):295-9. PubMed ID: 960237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific characters of serum MAO in dogs.
    Ikeno M; Oguchi K; Takahara K; Kinemuchi H; Kamijo K
    Biochem Exp Biol; 1978; 14(1):3-10. PubMed ID: 743481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-Thyroxine and monoamine oxidase activity in the kidney and some other organs of the rat.
    Moonat LB; Asaad MM; Clarke DE
    Res Commun Chem Pathol Pharmacol; 1975 Dec; 12(4):765-79. PubMed ID: 1215664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asparagus racemosus competitively inhibits in vitro the acetylcholine and monoamine metabolizing enzymes.
    Meena J; Ojha R; Muruganandam AV; Krishnamurthy S
    Neurosci Lett; 2011 Sep; 503(1):6-9. PubMed ID: 21843599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aging on monoamine oxidase activity of mouse and rabbit tissues.
    Feldman JM; Roche JM
    Exp Aging Res; 1978 Apr; 4(2):97-107. PubMed ID: 648554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fluorostigmine, toxogonin and atropine on monoamine oxidase activity and the level of biogenic amines in mouse brain.
    Kleinrok Z; Jagiełło-Wójtowicz E; Sieklucka-Dziuba M
    Acta Physiol Pol; 1979; 30(4):437-44. PubMed ID: 388982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of eltroxine and neomercazol on monoamine oxidase from rat tissues.
    Kaul P; Srinivasan S; Udupa KN
    Indian J Physiol Pharmacol; 1975; 19(2):65-70. PubMed ID: 1158431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histochemical and biochemical investigations of monoamine oxidase activity level in the brain of the brindled mouse].
    Yoshimura N; Sato T; Takahashi A; Akanuma J; Nishimura M
    No To Shinkei; 1991 Oct; 43(10):939-44. PubMed ID: 1799497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does long term treatment with amitriptyline alter the monoamine oxidase of rat brain?
    Honecker H; Hill R
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):32-5. PubMed ID: 887646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.